Discover The iCELLis™ 50 Bioreactor System

The iCELLis™ 50 bioreactor offers a streamlined solution for intermediate-scale viral vector and vaccine manufacturing. As part of the iCELLis™ family of single-use, fixed-bed bioreactors, it bridges the gap between small-scale development and large-scale commercial production. With scalable performance from 0.5 to 500 square meters, the system supports a wide range of applications, including viral vectors, exosomes, and vaccines. Its geometrically similar design to the iCELLis™ 500+ enables seamless scale-up, reducing complexity and risk in process development. Whether you're advancing toward clinical trials or preparing for commercial launch, the iCELLis™ 50 helps simplify your path forward.

Explore how this intermediate-scale system can accelerate your manufacturing journey without compromising consistency or control.